Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
MILLENNIUM LABORATORIES via DLA PIPER LLP (US)
2014 · fourth_quarter · 4T
Medicare reimbursement and coverage issues related to diagnostic testing; Prescription drug abuse.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2014 · fourth_quarter · 4T
Source: Senate LDA
| ALLIANCE FOR CONNECTED CARE |
| 4 |
| 2014 |
| MILLENNIUM LABORATORIES | 4 | 2014 |
| EMD SERONO, INC. | 2 | 2013 |
| Rite Aid Corporation | 2 | 2013 |
| AVALON HEALTH MANAGEMENT | 1 | 2013 |
| ICIX INTERNATIONAL LTD | 1 | 2013 |
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
S. 1871, SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013 and H.R. 4302, Protecting Access to Medicare Act of 2014, provisions related to health IT.
S. 1871, SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013 and H.R. 4302, Protecting Access to Medicare Act of 2014, provisions related to health IT.
Medicare Diabetes Prevention Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Medicare Diabetes Prevention Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.
Medicare Diabetes Prevention Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Medicare Diabetes Prevention Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Supporting the goals and ideals of the MAGIC Foundation.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Supporting the goals and ideals of the MAGIC Foundation.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Supporting the goals and ideals of the MAGIC Foundation.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: AETNA, INC. · Firm: DLA PIPER LLP (US)
S. 1871, SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013 and H.R. 4302, Protecting Access to Medicare Act of 2014, provisions related to health IT.
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: AETNA, INC. · Firm: DLA PIPER LLP (US)
S. 1871, SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013 and H.R. 4302, Protecting Access to Medicare Act of 2014, provisions related to health IT.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Telehealth Promotion Act of 2012
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: DLA PIPER LLP (US)
Telehealth Promotion Act of 2012 (H.R. 6719 in the 112th Congress).
Telehealth Promotion Act of 2012
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: DLA PIPER LLP (US)
Telehealth Promotion Act of 2012 (H.R. 6719 in the 112th Congress).
Medication Therapy Management Empowerment Act of 2013
Client: RITE AID CORPORATION · Firm: DLA PIPER LLP (US)
Legislation affecting retail pharmacies; H.R. 1024/S. 557, Medication Therapy Management Empowerment Act of 2013; S. 644, PACT Act; H.R. 1285/S. 621, Safe Prescribing Act of 2013; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 957, Drug Supply Chain Security Act.
Medication Therapy Management Empowerment Act of 2013
Client: RITE AID CORPORATION · Firm: DLA PIPER LLP (US)
Legislation affecting retail pharmacies; H.R. 1024/S. 557, Medication Therapy Management Empowerment Act of 2013; S. 644, PACT Act; H.R. 1285/S. 621, Safe Prescribing Act of 2013; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 957, Drug Supply Chain Security Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization. S. Res. 242, supporting the goals and ideals of "Growth Awareness Week." H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Preventing Diabetes in Medicare Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011. H.R. 8, American Taxpayer Relief Act of 2012. H.R. 1588/S. 740, Medicare Drug Savings Act of 2013. H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Preventing Diabetes in Medicare Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Preventing Diabetes in Medicare Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: RITE AID CORPORATION · Firm: DLA PIPER LLP (US)
Legislation affecting retail pharmacies; H.R. 1024/S. 557, Medication Therapy Management Empowerment Act of 2013; S. 644, PACT Act; H.R. 1285/S. 621, Safe Prescribing Act of 2013; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 957, Drug Supply Chain Security Act.
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: RITE AID CORPORATION · Firm: DLA PIPER LLP (US)
Legislation affecting retail pharmacies; H.R. 1024/S. 557, Medication Therapy Management Empowerment Act of 2013; S. 644, PACT Act; H.R. 1285/S. 621, Safe Prescribing Act of 2013; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 957, Drug Supply Chain Security Act.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011. H.R. 8, American Taxpayer Relief Act of 2012. H.R. 1588/S. 740, Medicare Drug Savings Act of 2013. H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
H.R. 1851/S. 881, Family Act of 2013.
H.R. 1851/S. 881, Family Act of 2013.
Safeguarding America's Pharmaceuticals Act of 2013
Client: RITE AID CORPORATION · Firm: DLA PIPER LLP (US)
Legislation affecting retail pharmacies; H.R. 1024/S. 557, Medication Therapy Management Empowerment Act of 2013; S. 644, PACT Act; H.R. 1285/S. 621, Safe Prescribing Act of 2013; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 957, Drug Supply Chain Security Act.
Safeguarding America's Pharmaceuticals Act of 2013
Client: RITE AID CORPORATION · Firm: DLA PIPER LLP (US)
Legislation affecting retail pharmacies; H.R. 1024/S. 557, Medication Therapy Management Empowerment Act of 2013; S. 644, PACT Act; H.R. 1285/S. 621, Safe Prescribing Act of 2013; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 957, Drug Supply Chain Security Act.
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: AETNA, INC. · Firm: DLA PIPER LLP (US)
S. 1871, SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013; H.R. 2810, Medicare Patient Access and Quality Improvement Act of 2013, provisions related to health IT.
Medicare Diabetes Prevention Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Medicare Diabetes Prevention Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Medicare Diabetes Prevention Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011. H.R. 8, American Taxpayer Relief Act of 2012. H.R. 1588/S. 740, Medicare Drug Savings Act of 2013. H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Supporting the goals and ideals of the MAGIC Foundation.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization. S. Res. 242, supporting the goals and ideals of "Growth Awareness Week." H. Res. 313, supporting the goals and ideals of the MAGIC Foundation.
Supporting the goals and ideals of the MAGIC Foundation.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization. S. Res. 242, supporting the goals and ideals of "Growth Awareness Week." H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: AETNA, INC. · Firm: DLA PIPER LLP (US)
S. 1871, SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013; H.R. 2810, Medicare Patient Access and Quality Improvement Act of 2013, provisions related to health IT.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011. H.R. 8, American Taxpayer Relief Act of 2012. H.R. 1588/S. 740, Medicare Drug Savings Act of 2013. H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization. S. Res. 242, supporting the goals and ideals of "Growth Awareness Week." H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Medication Therapy Management Empowerment Act of 2013
Client: RITE AID CORPORATION · Firm: DLA PIPER LLP (US)
Legislation affecting retail pharmacies; H.R. 1024/S. 557, Medication Therapy Management Empowerment Act of 2013; S. 644, PACT Act; H.R. 1285/S. 621, Safe Prescribing Act of 2013; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 957, Drug Supply Chain Security Act.
Medication Therapy Management Empowerment Act of 2013
Client: RITE AID CORPORATION · Firm: DLA PIPER LLP (US)
Legislation affecting retail pharmacies; H.R. 1024/S. 557, Medication Therapy Management Empowerment Act of 2013; S. 644, PACT Act; H.R. 1285/S. 621, Safe Prescribing Act of 2013; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 957, Drug Supply Chain Security Act.
Legislation affecting retail pharmacies; H.R. 1024/S. 557, Medication Therapy Management Empowerment Act of 2013; S. 644, PACT Act; H.R. 1285/S. 621, Safe Prescribing Act of 2013; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 957, Drug Supply Chain Security Act.
Legislation affecting retail pharmacies; H.R. 1024/S. 557, Medication Therapy Management Empowerment Act of 2013; S. 644, PACT Act; H.R. 1285/S. 621, Safe Prescribing Act of 2013; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 957, Drug Supply Chain Security Act.
Legislation affecting retail pharmacies; H.R. 1024/S. 557, Medication Therapy Management Empowerment Act of 2013; S. 644, PACT Act; H.R. 1285/S. 621, Safe Prescribing Act of 2013; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 957, Drug Supply Chain Security Act.
Legislation affecting retail pharmacies; H.R. 1024/S. 557, Medication Therapy Management Empowerment Act of 2013; S. 644, PACT Act; H.R. 1285/S. 621, Safe Prescribing Act of 2013; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 957, Drug Supply Chain Security Act.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011. H.R. 8, American Taxpayer Relief Act of 2012. H.R. 1588/S. 740, Medicare Drug Savings Act of 2013. H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
H.R. 1851/S. 881, Family Act of 2013.
H.R. 1851/S. 881, Family Act of 2013.
Legislation affecting retail pharmacies; H.R. 1024/S. 557, Medication Therapy Management Empowerment Act of 2013; S. 644, PACT Act; H.R. 1285/S. 621, Safe Prescribing Act of 2013; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 957, Drug Supply Chain Security Act.
Legislation affecting retail pharmacies; H.R. 1024/S. 557, Medication Therapy Management Empowerment Act of 2013; S. 644, PACT Act; H.R. 1285/S. 621, Safe Prescribing Act of 2013; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 957, Drug Supply Chain Security Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization. S. Res. 242, supporting the goals and ideals of "Growth Awareness Week." H. Res. 313, supporting the goals and ideals of the MAGIC Foundation.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization. S. Res. 242, supporting the goals and ideals of "Growth Awareness Week." H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Telehealth Promotion Act of 2012
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: DLA PIPER LLP (US)
Implementation of Public Law 111-148, provisions related to the employer mandate. Telehealth Promotion Act of 2012 (H.R. 6719 in the 112th Congress). Implementation of Public Law No. 112-240, provisions on Commission on Long-Term Care.
Telehealth Promotion Act of 2012
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: DLA PIPER LLP (US)
Implementation of Public Law 111-148, provisions related to the employer mandate. Telehealth Promotion Act of 2012 (H.R. 6719 in the 112th Congress). Implementation of Public Law No. 112-240, provisions on Commission on Long-Term Care.
Telehealth Promotion Act of 2012
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: DLA PIPER LLP (US)
Implementation of Public Law 111-148, provisions related to the employer mandate. Telehealth Promotion Act of 2012 (H.R. 6719 in the 112th Congress). Implementation of Public Law No. 112-240, provisions on Commission on Long-Term Care.
Telehealth Promotion Act of 2012
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: DLA PIPER LLP (US)
Implementation of Public Law 111-148, provisions related to the employer mandate. Telehealth Promotion Act of 2012 (H.R. 6719 in the 112th Congress). Implementation of Public Law No. 112-240, provisions on Commission on Long-Term Care.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011. H.R. 8, American Taxpayer Relief Act of 2012. H.R. 1588/S. 740, Medicare Drug Savings Act of 2013. H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Issues related to Medicare and Medicaid reimbursements.
AETNA, INC. via DLA PIPER LLP (US)
2014 · fourth_quarter · 4T
Implementation of Public Law No. 111-148, provisions related to health IT.
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2014 · fourth_quarter · 4T
Implementation of Public Law No. 111-148; issues related to the Federal Employee Health Benefits Program.
CENSEOHEALTH via DLA PIPER LLP (US)
2014 · fourth_quarter · 4T
Medicare Advantage risk adjustment.
HUMETRIX via DLA PIPER LLP (US)
2014 · fourth_quarter · 4T
Consumer access to health data and interoperability. H.R. 3230, Veterans Access Choice and Accountability Act of 2013, provisions related to health IT.
CENSEOHEALTH via DLA PIPER LLP (US)
2014 · third_quarter · Q3
Medicare Advantage risk adjustment.
HUMETRIX via DLA PIPER LLP (US)
2014 · third_quarter · Q3
Consumer access to health data and interoperability. H.R. 3230, Veterans Access Choice and Accountability Act of 2013, provisions related to health IT.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE FOR CONNECTED CARE via DLA PIPER LLP (US)
2014 · third_quarter · Q3
Modernize federal policies regarding telehealth and remote patient monitoring.
Modernize federal policies regarding telehealth and remote patient monitoring.
Filing targets: Executive Office of the President (EOP), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2014 · third_quarter · Q3
Implementation of Public Law No. 111-148; issues related to the Federal Employee Health Benefits Program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2014 · third_quarter · Q3
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2014 · third_quarter · Q3
Issues related to Medicare and Medicaid reimbursements.
MILLENNIUM LABORATORIES via DLA PIPER LLP (US)
2014 · third_quarter · Q3
Medicare reimbursement and coverage issues related to diagnostic testing; Prescription drug abuse.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AETNA, INC. via DLA PIPER LLP (US)
2014 · third_quarter · Q3
Implementation of Public Law No. 111-148, provisions related to health IT.
MILLENNIUM LABORATORIES via DLA PIPER LLP (US)
2014 · second_quarter · Q2
Medicare reimbursement and prescription drug abuse.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2014 · second_quarter · Q2
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HUMETRIX via DLA PIPER LLP (US)
2014 · second_quarter · Q2
Consumer access to health data and interoperability.
Filing targets: Executive Office of the President (EOP), Health & Human Services, Dept of (HHS)
ALLIANCE FOR CONNECTED CARE via DLA PIPER LLP (US)
2014 · second_quarter · Q2
Modernize federal policies regarding telehealth and remote patient monitoring.
Modernize federal policies regarding telehealth and remote patient monitoring.
Filing targets: Executive Office of the President (EOP), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CENSEOHEALTH via DLA PIPER LLP (US)
2014 · second_quarter · Q2
Medicare Advantage risk adjustment.
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2014 · second_quarter · Q2
Implementation of Public Law No. 111-148; issues related to the Federal Employee Health Benefits Program.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AETNA, INC. via DLA PIPER LLP (US)
2014 · second_quarter · Q2
S. 1871, SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013 and H.R. 4302, Protecting Access to Medicare Act of 2014, provisions related to health IT.
Implementation of Public Law No. 111-148, provisions related to preventative services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2014 · second_quarter · Q2
Telehealth Promotion Act of 2012 (H.R. 6719 in the 112th Congress).
Issues related to Medicare and Medicaid reimbursements.
Filing targets: SENATE
MILLENNIUM LABORATORIES via DLA PIPER LLP (US)
2014 · second_quarter · RR
Medicare coverage policies.
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2014 · first_quarter · Q1
Implementation of Public Law No. 111-148; issues related to the Federal Employee Health Benefits Program.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE FOR CONNECTED CARE via DLA PIPER LLP (US)
2014 · first_quarter · Q1
Modernize federal policies regarding telehealth and remote patient monitoring.
Modernize federal policies regarding telehealth and remote patient monitoring.
Filing targets: Executive Office of the President (EOP), SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2014 · first_quarter · 1A
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2014 · first_quarter · Q1
Issues related to Medicare and Medicaid reimbursements.
Telehealth Promotion Act of 2012 (H.R. 6719 in the 112th Congress).
CENSEOHEALTH via DLA PIPER LLP (US)
2014 · first_quarter · Q1
Medicare Advantage risk adjustment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HUMETRIX via DLA PIPER LLP (US)
2014 · first_quarter · Q1
Consumer access to health data.
AETNA, INC. via DLA PIPER LLP (US)
2014 · first_quarter · Q1
S. 1871, SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013 and H.R. 4302, Protecting Access to Medicare Act of 2014, provisions related to health IT.
Implementation of Public Law No. 111-148, provisions related to preventative services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2014 · first_quarter · Q1
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR CONNECTED CARE via DLA PIPER LLP (US)
2014 · first_quarter · RR
Modernize federal policies regarding telehealth and remote patient monitoring.
Modernize federal policies regarding telehealth and remote patient monitoring.
CENSEOHEALTH via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
Medicare Advantage risk adjustment.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
CENSEOHEALTH via DLA PIPER LLP (US)
2013 · fourth_quarter · RR
Medicare Advantage risk adjustment
AETNA, INC. via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
Implementation of Public Law No. 111-148, provisions related to CMS Innovation Center programs; care coordination initiatives; health information technology.
S. 1871, SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013; H.R. 2810, Medicare Patient Access and Quality Improvement Act of 2013, provisions related to health IT.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMD SERONO, INC. via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
H.R. 1851/S. 881, Family Act of 2013.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HUMETRIX via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
Consumer access to health data.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
Implementation of Public Law 111-148, provisions related to the employer mandate. Telehealth Promotion Act of 2012 (H.R. 6719 in the 112th Congress). Implementation of Public Law No. 112-240, provisions on Commission on Long-Term Care.
Issues related to Medicare and Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
RITE AID CORPORATION via DLA PIPER LLP (US)
2013 · fourth_quarter · 4T
Legislation affecting retail pharmacies; H.R. 1024/S. 557, Medication Therapy Management Empowerment Act of 2013; S. 644, PACT Act; H.R. 1285/S. 621, Safe Prescribing Act of 2013; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 957, Drug Supply Chain Security Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization. S. Res. 242, supporting the goals and ideals of "Growth Awareness Week." H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
Implementation of Public Law No. 111-148; issues related to the Federal Employee Health Benefits Program.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMD SERONO, INC. via DLA PIPER LLP (US)
2013 · third_quarter · Q3
H.R. 1851/S. 881, Family Act of 2013.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2013 · third_quarter · Q3
Issues related to Medicare and Medicaid reimbursements.
Implementation of Public Law 111-148, provisions related to the employer mandate. Telehealth Promotion Act of 2012 (H.R. 6719 in the 112th Congress). Implementation of Public Law No. 112-240, provisions on Commission on Long-Term Care.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
AETNA, INC. via DLA PIPER LLP (US)
2013 · third_quarter · Q3
Implementation of Public Law No. 111-148, provisions related to CMS Innovation Center programs; care coordination initiatives; health information technology; wellness initiatives.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2013 · third_quarter · Q3
Implementation of Public Law No. 111-148; issues related to the Federal Employee Health Benefits Program.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2013 · third_quarter · Q3
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization. S. Res. 242, supporting the goals and ideals of "Growth Awareness Week." H. Res. 313, supporting the goals and ideals of the MAGIC Foundation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
HUMETRIX via DLA PIPER LLP (US)
2013 · third_quarter · Q3
Consumer access to health data.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
RITE AID CORPORATION via DLA PIPER LLP (US)
2013 · third_quarter · Q3
Legislation affecting retail pharmacies; H.R. 1024/S. 557, Medication Therapy Management Empowerment Act of 2013; S. 644, PACT Act; H.R. 1285/S. 621, Safe Prescribing Act of 2013; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 957, Drug Supply Chain Security Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2013 · second_quarter · Q2
Issues related to Medicare and Medicaid reimbursements.
Implementation of Public Law 111-148, provisions related to the employer mandate. Telehealth Promotion Act of 2012 (H.R. 6719 in the 112th Congress). Implementation of Public Law No. 112-240, provisions on Commission on Long-Term Care.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2013 · second_quarter · Q2
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011. H.R. 8, American Taxpayer Relief Act of 2012. H.R. 1588/S. 740, Medicare Drug Savings Act of 2013. H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2013 · second_quarter · Q2
Implementation of Public Law No. 111-148; issues related to the Federal Employee Health Benefits Program.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
HUMETRIX via DLA PIPER LLP (US)
2013 · second_quarter · Q2
Consumer access to health data.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
ICIX INTERNATIONAL LTD via DLA PIPER LLP (US)
2013 · second_quarter · Q2
Implementation of the Food Safety Modernization Act.
Implementation of Public Law No. 111-148, provisions related to the Physician Payments Sunshine Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AETNA, INC. via DLA PIPER LLP (US)
2013 · second_quarter · Q2
Implementation of Public Law No. 111-148, provisions related to CMS Innovation Center programs; care coordination initiatives; health information technology; wellness initiatives.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HUMETRIX via DLA PIPER LLP (US)
2013 · second_quarter · RR
Consumer access to health data.
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2013 · first_quarter · Q1
Issues related to Medicare and Medicaid reimbursements.
Implementation of Public Law 111-148, provisions related to the employer mandate. Telehealth Promotion Act of 2012 (H.R. 6719 in the 112th Congress). Implementation of Public Law No. 112-240, provisions on Commission on Long-Term Care.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2013 · first_quarter · Q1
Implementation of Public Law No. 111-148; issues related to the Federal Employee Health Benefits Program.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
AETNA, INC. via DLA PIPER LLP (US)
2013 · first_quarter · Q1
Implementation of Public Law No. 111-148, provisions related to CMS Innovation Center programs; Care coordination initiatives; health information technology; Wellness initiatives.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AVALON HEALTH MANAGEMENT via DLA PIPER LLP (US)
2013 · first_quarter · Q1
Implementation of the American Taxpayer Relief Act of 2012 (P.L. No. 112-240), creation of Commission on Long-Term Care.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE